3 completed, 1 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow solithromycin: new trials by email Literature Review of solithromycin trials Research Report on solithromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia Solithromycin, Standard of Care - Community-acquired Bacterial Pneumonia | Phase 2 / Phase 3 | Terminated | Melinta Therapeutics, Inc. | 97 | 2016-04-01 | 2019-01-03 |
| Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea solithromycin, ceftriaxone, azithromycin - Uncomplicated Urogenital Gonorrhea | Phase 3 | Completed | Melinta Therapeutics, Inc. | 264 | 2014-08-01 | 2017-09-11 |
| Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Solithromycin, Moxifloxacin - Community-acquired Bacterial Pneumonia | Phase 3 | Completed | Melinta Therapeutics, Inc. | 863 | 2013-11-01 | 2017-03-03 |
| Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Solithromycin, Moxifloxacin, Placebo to match solithromycin - Community-acquired Bacterial Pneumonia | Phase 3 | Completed | Melinta Therapeutics, Inc. | 860 | 2012-12-01 | 2017-03-03 |
Pneumonia (3) · Chlamydia Infections (1) · Gonorrhea (1)
Melinta Therapeutics, Inc. (4)
United States (4) · Bulgaria (3) · Hungary (3) · Spain (3) · Argentina (2) · Canada (2) · Germany (2) · Latvia (2) · Philippines (2) · Poland (2) · Romania (2) · Russia (2) · South Africa (2) · Australia (1) · Chile (1)
Brian D Jamieson, MD (1) · David Oldach, MD (1) · Marcus Chen, MD, PhD (1) · Michael Cohen-Wolkowiez, MD, PhD (1)